Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Ann Med Res. 1996; 3(1): 1-6


Serum immunoglobulin levels in rheumatoid arthritis: Is IgA level aıı activity criterion?

 

Dr. Süleyman Büyükberber*, Dr. Murat Turgay**, Dr. Gülay Kinikli**, Dr. Güner Tokgöz**

.




Abstract


 


/As a consequence of impaired immune regulatory mechanisms there is a hyperactivity of B lymphocytes and excessive immunoglobulin production in rheumatoid arthritis (RA). Elevated levels of IgG and IgA are shown in several studies. In this study, we measured the immunoglobulin levels of the patients with RA in both activation and remission periods, and tried to determine if the IgA levels can be used as an activity criterion. We also tried to determine the rate of the selective IgA deficiency in a large population of RA patients and correlation of these findings with other laboratory and clinical parameters.

The findings from these patients with RA suggest that: 1) Polyclonal hypergamaglobulinemia, which is seen in activation periods, is not seen in remission periods. 2) Elevation IgA levels seems to be a strong and elevation of IgG is a weak indicator for activity of RA. Also, the selective IgA deficiency, that is seen in. 025% to 0.03% of the normal population , was not present our RA patient group.

Key Words: Rheumatoid Arthritis (RA), Immunoglobulin A (IgA), Immunoglobulin ö (IgG)








Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.